Raeder, Vanessa
Boura, Iro
Leta, Valentina
Jenner, Peter
Reichmann, Heinz
Trenkwalder, Claudia
Klingelhoefer, Lisa
Chaudhuri, K. Ray
Article History
Accepted: 20 December 2020
First Online: 9 February 2021
Declarations
:
: The authors did not receive support from any organization for the submitted work. The open access fee was covered by the Department of Research and Innovation at King’s College Hospital London, UK
: Vanessa Raeder has no conflicts of interest. Iro Boura reports a congress grant from UCB, outside the submitted work. Valentina Leta reports personal fees from Britannia Pharmaceuticals, personal fees from Invisio Pharmaceuticals, grants from Parkinson’s UK, grants from Bial, outside the submitted work. Peter Jenner reports consultancies and Advisory Boards for Abbvie, Bial, Eisai, Kyowa Kirin, Lundbeck, FP Pharmaceuticals, Profile Pharma, UCB, Worldwide Clinical Trials, Zambon, outside the submitted work. Heinz Reichmann was acting on Advisory Boards, gave lectures and received research grants from Abbott, Abbvie, Bayer Health Care, Bial, Boehringer/Ingelheim, Brittania, Cephalon, Desitin, GSK, Lundbeck, Medtronic, Merck-Serono, Novartis, Orion, Pfizer, TEVA, UCB Pharma, Valeant, and Zambon, outside the submitted work. Lisa Klingelhoefer reports academic grants from EU Horizon 2020; habilitation funding for women from the Medical Faculty of the Technical University Dresden, Germany; research support by the university of excellence of TU Dresden funded by the excellence strategy of the federal and state governments (Str1911_038) without any influence on scientific contents, outside the submitted work. Claudia Trenkwalder reports grants from Britannia, Roche, M.J. Fox (European grant: program Horizon 2020), UCB, Gruenenthal, Otsuka, outside the submitted work. K. Ray Chaudhuri reports advisory board for AbbVie, UCB, GKC, Bial, Cynapsus, Novartis, Lobsor, Stada, Medtronic, Zambon, Profile, Sunovion, Roche, Theravance, Scion, Britannia; honoraria for lectures from AbbVie, Britannia, UCB, Mundipharma, Zambon, Novartis, Boeringer Ingelheim; grants (Investigator Initiated) from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial; academic grants from EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust, outside the submitted work.
: Data sharing not applicable to this article as no datasets were generated or analysed during the current study.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: KRC conceived of the idea. VR, IB, VL performed the literature search. VR, IB, VL and KRC wrote the first draft of the paper. All authors critically revised the manuscript. All authors read and approved the final manuscript.